Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.

Arteriosclerosis, thrombosis, and vascular biology - 1 Apr 2007

Ladenvall Claes, Gils Ann, Jood Katarina, Blomstrand Christian, Declerck Paul J, Jern Christina

Abstract excerpt

OBJECTIVE: Thrombin activatable fibrinolysis inhibitor (TAFI) attenuates fibrinolysis. The aim of the present study was to investigate the possible association between TAFI and overall ischemic stroke and ischemic stroke subtypes. METHODS AND RESULTS: The Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS) comprises 600 cases (18 to 69 years) and 600 matched population controls. Stroke subtype was defined by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Ischemia
Share to Carboxypeptidase B2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cerebral Infarction

Share to Chromosome Mapping

Share to Haplotypes

Share to Linkage Disequilibrium

Share to Stroke

Share to Time Factors

Source

Identifiers

PMID: 17272741
DOI: 10.1161/01.ATV.0000259354.93789.a6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.PMID 17272741Read ↗

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.Semantic proximity Read ↗

High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke.Semantic proximity Read ↗

Fibrinolytic gene polymorphism and ischemic stroke.Semantic proximity Read ↗

Prevention of ischemic stroke: overview of traditional risk factors.Semantic proximity Read ↗

Fibrinogen gene variation and ischemic stroke.Semantic proximity Read ↗

Plasma factor VII-activating protease antigen levels and activity are increased in ischemic stroke.Semantic proximity Read ↗

Angiotensin converting enzyme polymorphism and ischemic stroke.Semantic proximity Read ↗

A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.Semantic proximity Read ↗

Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype.Semantic proximity Read ↗

Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study.Semantic proximity Read ↗

Genetic variants of coagulation factor XI show association with ischemic stroke up to 70 years of age.Semantic proximity Read ↗

Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.